Since several substrates of matriptase, such as urokinase (uPA), stromelysin (MMP3), pro-HGF (hepatocyte growth factor), and PAR2 (protease-activated receptor 2), were implicated in cancer progression16–18, the role of matriptase in cancers has been intensely addressed recently. Here, F2RL1 is linked to cancer.